Veracyte Gets $45M In Financing
South San Francisco-based molecular diagnostics developer Veracyte said earlier this week that it has raised $45M in financing, from Visium Healthcare Partners LP. Publicly held Veracyte said the financing comes in a com bination of a term loan agreement and securities purchase option. Veracyte said it will initially received $25M from Visium, of which $5M will go towards paying off an existing loan with Silicon Valley Bank.
posted on Thursday, March 31, 2016
Related companies:
Veracyte
Related stories:
> Veracyte Slips Slightly In IPO Debut
> Veracyte Files For IPO
> Veracyte Gets $28M In Series C For Molecular Diagnostics Products
> Veracyte Gets $28M
> KANA Gets $1M In Debt Financing
silicontap.com Home